Shu Zhang

机构：Nanjing University of Chinese Medicine, Nanjing Drum Tower Hospital, Nanjing University

发表论文 13 篇 · 总被引 358 次 · h-index 8

代表论文

• Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis (2023 · Nature Communications · 被引 198)
• Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations (2022 · Oncogene · 被引 31)
• CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma (2023 · Advanced Science · 被引 30)
• High-throughput enrichment of portal venous circulating tumor cells for highly sensitive diagnosis of CA19-9-negative pancreatic cancer patients using inertial microfluidics (2024 · Biosensors and Bioelectronics · 被引 27)
• Pirfenidone-loaded exosomes derived from pancreatic ductal adenocarcinoma cells alleviate fibrosis of premetastatic niches to inhibit liver metastasis (2022 · Biomaterials Science · 被引 19)
• An oncolytic system produces oxygen selectively in pancreatic tumor cells to alleviate hypoxia and improve immune activation (2024 · Pharmacological Research · 被引 11)